Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model.
Stefan Michael SattlerAnniek F LubberdingLasse SkibsbyeReza JabbariReza WakiliThomas JespersenJacob Tfelt-HansenPublished in: Journal of cardiovascular translational research (2019)
Ventricular fibrillation (VF) occurring in the first minutes to hours of acute myocardial infarction (AMI) is a frequent cause of death and treatment options are limited. The aim was to test whether early infusion of amiodarone 10 min after onset of AMI reduced the incidence of VF in a porcine model. Eighteen female Danish landrace pigs were randomized to a control and an amiodarone group. AMI was induced by ligation of the mid-left anterior descending artery for 120 min followed by 60 min of reperfusion. VF occurred in 0/8 pigs treated with amiodarone compared to 7/10 controls (P < 0.01). Amiodarone treatment prolonged RR intervals, reduced dispersion of action potential duration in the infarcted area and mean number of ectopic beats. No negative effects on cardiac output and blood pressure were observed with amiodarone. Amiodarone qualifies as a potential drug candidate to prevent VF in the first minutes to hours of AMI.
Keyphrases
- acute myocardial infarction
- left ventricular
- percutaneous coronary intervention
- blood pressure
- heart failure
- emergency department
- type diabetes
- double blind
- low dose
- randomized controlled trial
- human health
- clinical trial
- risk assessment
- adipose tissue
- heart rate
- open label
- insulin resistance
- catheter ablation
- acute ischemic stroke
- phase iii
- climate change
- newly diagnosed
- skeletal muscle
- electronic health record
- drug induced
- placebo controlled